Brief Overview of the SEBIO 2007 Agenda:

Wednesday, November 7

Historic Walking Tour of Pinehurst

SEBIO Golf Outing - 9:15 am Tee Time

Opening Luncheon Keynote Panel - 12:30 pm
Big Pharma Business Development - What Emerging Companies Want to Know

Kenneth Lee - General Partner, Hatteras Venture Partners - Moderator

Rick Anderson - Company Group Chairman,Johnson & Johnson and Worldwide Franchise Chairman, Cordis Corporation

Leslie Boyd - Vice President of Scientific Licensing, GlaxoSmithKline

Edward T. Mathers - Executive Vice President, Corporate Development and Venture, MedImmune

Main-Stage Company Presentations

Biofisica, Inc. - 2:00 pm
Transfusion & Transplantation Tech LLC (3Ti) - 2:15 pm
Xhale Diagnostics, Inc. - 2:30 pm
NovaMin Technology Inc. - 2:45 pm
Metastatix, Inc. - 3:00 pm
InnerPulse Inc. - 3:15 pm
AerovectRx Corporation - 3:30 pm

Break - 3:45 pm - 4:15 pm

Patent Law Panel - 4:15 pm - 5:15 pm
Impact of the Recent Patent Rule Changes on Emerging Companies and Technology Transfer

Allen R. Baum - Hutchison Law Group PLLC

Margaret Bolce Brivanlou, PhD - King and Spalding

Douglas Gooding - Regado Biosciences, Inc

Jamie L. Greene - Kilpatrick Stockton LLP

Todd T. Sherer, PhD - Emory University

Early-Stage Company Shootout - 5:15 pm - 6:15 pm
A panel of celebrity judges, made up of senior venture capitalists, will assess each participant on the quality of four Early-stage presentations, the viability of the venture, and the overall fundability of the opportunity. Finally, the judges will score and tabulate their assessments and select an overall winner of the competition. The four Early-Stage Shootout finalists will be recognized during the forum.

Gala Reception - 7:00 pm - 10:00 pm
The Donald Ross Grill

VC Reception - 10:00 pm
Investors Only
Join the private equity industry leaders at this reception. This invitation-only event is a great opportunity for emerging venture capital leaders to socialize and interact. If you are interested in attending the VC event, please email dpoole@informedhorizons.com.

Thursday, November 8

5K Run - 6:30 am

Thursday Breakfast Sessions

Your choice of one of the following sessions...

Biotech/Pharma Breakfast Speaker - 8:30 am - 9:30 am
Managing to Get More for Your Assets

Tom Keelin - Managing Partner, Keelin Reeds Partners

Medical Devices Breakfast Panel - 8:30 am - 9:30 am
Models for Medical Device Commercialization

Nicholas Chronos, MD - Chief Scientific and Medical Officer, Saint Joseph's Research Institute

Edward Kerslake, MBA, PhD - Vice President Program Management & Business Operations, Corporate Research and Advanced Technology Development, Boston Scientific

BioPlan Competition Presentations - 9:30 am - 10:30 am

Main-Stage Company Presentations

Abeome Corporation - 10:45 am
Ercole Biotech - 11:00 am
Tikvah Therapeutics, Inc. - 11:15 am
Integrated Oncology Solutions, Inc. (IOS) - 11:30 am
Cognosci, Inc. - 11:45 am
Altor BioScience Corporation - 12:00 pm (noon)

Closing Luncheon Keynote Speaker - 12:15 pm - 1:45 pm
Biopharmaceutical Companies - The Challenges Ahead

Matthew Emmens - Chief Executive Officer and Chairman of the Management Committee, Shire Pharmaceuticals Group plc

Closing Remarks and Announcement of Early-Stage Shootout Winner, BioPlan Winner, and First Annual SEBIO Awards Ceremony- 1:45 pm